“DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients with CNS Glial Tumors. First Results” (2026) Voprosy onkologii, 72(2), p. OF-2504. doi:10.37469/0507-3758-2026-72-2-OF-2504.